Physician

Gordon Scott Bontrager, MD

According to 2025 Medicare claims, Gordon Bontrager, MD (NPI: 1780919829) practices family practice in the Logan, UT-ID market, with the plurality of this provider's patient population coming from Franklin, ID. This provider's primary affiliated billing organization is PRESTON FAMILY MEDICINE (NPI: 1891406112; TIN: 921154335) and primary practice location at 83263-1325. Bontrager is affiliated with the AnewCare Collaborative, LLC (ACO ID: A1241) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Bontrager's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 123 traditional Medicare patients, billed 422 HCPCS/CPT codes, and received $28,323 in Medicare payments. The top billing code was 91320 (Sarscv2 vac 30mcg trs-suc im). Part D data shows 2,014 prescription claims across 172 beneficiaries totaling $207,825 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). DME data shows 31 claims. Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,366 to $28,323. Similarly, Part D prescription costs have risen steadily, from $26,659 to $207,825. For DME billing, reported payments moved sharply higher in recent years, from $3,570 to $29,155.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	61	$2,366
2016	25	37	$1,017
2017	14	33	$930
2018	14	33	$729
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	72	238	$14,933
2024	123	422	$28,323

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	204	570	$26,659
2016	48	62	$1,329
2017	19	27	$840
2018	26	91	$6,819
2019	68	508	$64,591
2020	105	1,081	$97,347
2021	123	1,055	$183,114
2022	100	929	$95,853
2023	125	1,055	$79,913
2024	172	2,014	$207,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	17	$2,296
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	31	$294
2020	N/R	69	$2,844
2021	N/R	59	$2,821
2022	N/R	47	$1,908
2023	N/R	N/R	N/R
2024	N/R	31	$6,777

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
91320	Sarscv2 vac 30mcg trs-suc im	27	27	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	44	111	$92
90480	Admn sarscov2 vacc 1 dose	35	35	$40
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	38	40	$31
G0008	Administration of influenza virus vaccine	37	39	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	11	281	$60,506
Jardiance	Empagliflozin	24	1,176	$22,483
Xarelto	Rivaroxaban	29	1,075	$19,377
Mounjaro	Tirzepatide	14	420	$15,368
Eliquis	Apixaban	13	615	$11,557

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$5,353
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	16	$1,424

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$16	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gordon Scott Bontrager, MD?

Tedicare shows public-source Medicare data for Gordon Scott Bontrager, MD (NPI 1780919829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gordon Scott Bontrager, MD have ACO affiliation data?

Gordon Scott Bontrager, MD is shown with ACO affiliation data for AnewCare Collaborative, LLC (MSSP, ACO ID A1241) and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Gordon Scott Bontrager, MD?

Gordon Scott Bontrager, MD is linked to PRESTON FAMILY MEDICINE (billing NPI 1891406112) in the available physician profile data.

Does Gordon Scott Bontrager, MD have Open Payments data?

Gordon Scott Bontrager, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.